Medical-grade facials use advanced technologies and techniques to address specific skin concerns, promising to change the way ...
Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, and ...